XML 88 R56.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings (loss) per share (Tables)
 12 Months Ended
Dec. 31, 2023
Earnings per share [abstract]  
Disclosure of Determining the Numerator of Basic EPS
202320222021
Net income (loss) attributable to controlling shareholders1,592,065 (519,417)(1,358,813)
Numerator of basic EPS1,592,065 (519,417)(1,358,813)
In determining the numerator of diluted EPS, earnings attributable to the Group is allocated as follows:
202320222021
Numerator of basic EPS1,592,065 (519,417)(1,358,813)
Adjustments for expenses (revenues) related to potential common shares included in the net income attributable to controlling shareholders(a)
(79,062)— — 
Numerator of diluted EPS1,513,003 (519,417)(1,358,813)
The following table contains the earnings (loss) per share of the Group for the years ended December 31, 2023, 2022 and 2021 (in thousands except share and per share amounts):
202320222021
Numerator of basic EPS1,592,065 (519,417)(1,358,813)
Weighted average number of outstanding shares312,574,647 311,880,008 308,905,398 
Weighted average number of contingently issuable shares with conditions satisfied12,941 — — 
Denominator of basic EPS 312,587,588 311,880,008 308,905,398 
Basic earnings (loss) per share - R$5.09 (1.67)(4.40)
Numerator of diluted EPS1,513,003 (519,417)(1,358,813)
Denominator of basic EPS312,587,588 311,880,008 308,905,398 
Share-based instruments(a) (Note 16.3.1)
6,679,569 — — 
Denominator of diluted EPS 319,267,157 311,880,008 308,905,398 
Diluted earnings (loss) per share - R$4.74 (1.67)(4.40)
(a)Including share-based compensation, contingent consideration and non-compete agreement with founders of Linx. Diluted earnings per share are calculated by adjusting the weighted average number of shares outstanding, considering potentially convertible instruments. However, due to the loss for the years ended December 31, 2022 and 2021, these instruments issued have a non-diluting effect, therefore, they were not considered in the total number of outstanding shares to determine the diluted loss per share.
Schedule of Detail of potentially issuable common shares for purposes of Diluted EPS
2023
Shares issuable under share-based payment plans for which performance conditions have already been met
13,578,978 
Total weighted average shares that could have been purchased: compensation expense to be recognized in future periods divided by the weighted average market price of Company’s shares
(8,944,168)
Other total weighted average shares potentially issuable for no additional consideration
2,044,759 
Share-based instruments6,679,569